Name | Number of supported studies | Average coverage | |
---|---|---|---|
endothelial cell | 24 studies | 50% ± 18% | |
astrocyte | 19 studies | 50% ± 18% | |
oligodendrocyte | 16 studies | 80% ± 17% | |
oligodendrocyte precursor cell | 16 studies | 80% ± 21% | |
fibroblast | 14 studies | 44% ± 14% | |
glutamatergic neuron | 13 studies | 69% ± 24% | |
pericyte | 13 studies | 53% ± 22% | |
microglial cell | 12 studies | 39% ± 21% | |
GABAergic neuron | 11 studies | 66% ± 20% | |
mast cell | 11 studies | 53% ± 22% | |
smooth muscle cell | 10 studies | 38% ± 14% | |
epithelial cell | 9 studies | 34% ± 19% | |
macrophage | 9 studies | 33% ± 17% | |
adipocyte | 9 studies | 37% ± 9% | |
neuron | 8 studies | 57% ± 24% | |
retinal rod cell | 7 studies | 57% ± 34% | |
retinal ganglion cell | 7 studies | 66% ± 29% | |
retinal cone cell | 7 studies | 78% ± 21% | |
ciliated cell | 7 studies | 43% ± 24% | |
endothelial cell of lymphatic vessel | 7 studies | 44% ± 11% | |
interneuron | 6 studies | 65% ± 19% | |
amacrine cell | 6 studies | 47% ± 25% | |
retina horizontal cell | 6 studies | 62% ± 28% | |
mesothelial cell | 6 studies | 40% ± 14% | |
retinal bipolar neuron | 5 studies | 65% ± 27% | |
cardiac muscle cell | 5 studies | 33% ± 8% | |
basal cell | 5 studies | 51% ± 23% | |
club cell | 5 studies | 52% ± 23% | |
type I pneumocyte | 5 studies | 36% ± 8% | |
type II pneumocyte | 5 studies | 55% ± 9% | |
cholangiocyte | 4 studies | 59% ± 18% | |
granule cell | 4 studies | 72% ± 11% | |
Mueller cell | 4 studies | 57% ± 16% | |
OFF-bipolar cell | 4 studies | 84% ± 17% | |
ON-bipolar cell | 4 studies | 80% ± 16% | |
hepatic stellate cell | 3 studies | 44% ± 23% | |
differentiation-committed oligodendrocyte precursor | 3 studies | 84% ± 9% | |
GABAergic interneuron | 3 studies | 66% ± 6% | |
glial cell | 3 studies | 64% ± 4% | |
progenitor cell | 3 studies | 41% ± 8% | |
GABAergic amacrine cell | 3 studies | 76% ± 11% | |
glycinergic amacrine cell | 3 studies | 57% ± 9% | |
rod bipolar cell | 3 studies | 84% ± 20% | |
endothelial cell of vascular tree | 3 studies | 41% ± 18% | |
hepatocyte | 3 studies | 63% ± 23% | |
ependymal cell | 3 studies | 60% ± 16% | |
capillary endothelial cell | 3 studies | 54% ± 3% | |
myofibroblast cell | 3 studies | 41% ± 19% | |
respiratory goblet cell | 3 studies | 66% ± 23% | |
muscle cell | 3 studies | 38% ± 24% | |
goblet cell | 3 studies | 46% ± 36% | |
transit amplifying cell | 3 studies | 44% ± 35% | |
mucus secreting cell | 3 studies | 65% ± 3% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 100% | 8983.06 | 2641 / 2642 | 100% | 28.67 | 702 / 705 |
breast | 100% | 2622.61 | 459 / 459 | 99% | 14.99 | 1108 / 1118 |
intestine | 100% | 5135.13 | 964 / 966 | 99% | 14.25 | 523 / 527 |
stomach | 100% | 2654.51 | 359 / 359 | 99% | 14.89 | 282 / 286 |
prostate | 99% | 1936.42 | 243 / 245 | 99% | 12.59 | 499 / 502 |
esophagus | 99% | 4012.92 | 1430 / 1445 | 98% | 14.50 | 180 / 183 |
lung | 99% | 2533.31 | 572 / 578 | 98% | 11.27 | 1127 / 1155 |
ovary | 97% | 1609.02 | 175 / 180 | 98% | 12.62 | 421 / 430 |
kidney | 99% | 2285.97 | 88 / 89 | 95% | 13.62 | 855 / 901 |
skin | 97% | 1982.22 | 1757 / 1809 | 96% | 12.77 | 454 / 472 |
thymus | 99% | 1933.02 | 646 / 653 | 94% | 10.63 | 570 / 605 |
pancreas | 95% | 1508.22 | 311 / 328 | 96% | 9.46 | 170 / 178 |
adrenal gland | 97% | 1543.90 | 250 / 258 | 92% | 12.94 | 211 / 230 |
uterus | 99% | 2326.04 | 168 / 170 | 89% | 8.71 | 409 / 459 |
bladder | 100% | 2718.86 | 21 / 21 | 86% | 7.58 | 432 / 504 |
ureter | 0% | 0 | 0 / 0 | 100% | 4.11 | 1 / 1 |
adipose | 99% | 2455.31 | 1197 / 1204 | 0% | 0 | 0 / 0 |
muscle | 98% | 1863.53 | 785 / 803 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 98% | 11.68 | 78 / 80 |
tonsil | 0% | 0 | 0 / 0 | 96% | 9.31 | 43 / 45 |
blood vessel | 94% | 1837.52 | 1254 / 1335 | 0% | 0 | 0 / 0 |
heart | 89% | 1571.83 | 769 / 861 | 0% | 0 | 0 / 0 |
liver | 20% | 217.15 | 46 / 226 | 53% | 3.47 | 215 / 406 |
spleen | 60% | 718.93 | 144 / 241 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 7% | 0.26 | 2 / 29 |
peripheral blood | 1% | 9.91 | 9 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0015031 | Biological process | protein transport |
GO_0090630 | Biological process | activation of GTPase activity |
GO_0005737 | Cellular component | cytoplasm |
GO_0005525 | Molecular function | GTP binding |
GO_0005096 | Molecular function | GTPase activator activity |
GO_0005515 | Molecular function | protein binding |
GO_0046872 | Molecular function | metal ion binding |
GO_0005543 | Molecular function | phospholipid binding |
GO_0003924 | Molecular function | GTPase activity |
Gene name | AGAP1 |
Protein name | Arf-GAP with GTPase, ANK repeat and PH domain-containing protein 1 (AGAP-1) (Centaurin-gamma-2) (Cnt-g2) (GTP-binding and GTPase-activating protein 1) (GGAP1) ArfGAP with GTPase domain, ankyrin repeat and PH domain 1 |
Synonyms | CENTG2 KIAA1099 |
Description | FUNCTION: GTPase-activating protein for ARF1 and, to a lesser extent, ARF5. Directly and specifically regulates the adapter protein 3 (AP-3)-dependent trafficking of proteins in the endosomal-lysosomal system. . |
Accessions | C9J8Z2 ENST00000699337.1 B2RZG9 A0A0U1RRF1 Q9UPQ3 H7C0A7 ENST00000402604.6 X5D293 ENST00000635100.2 ENST00000448025.6 E7EUN2 H7C211 ENST00000418654.2 ENST00000336665.9 [Q9UPQ3-2] ENST00000409457.5 [Q9UPQ3-3] ENST00000304032.13 [Q9UPQ3-1] ENST00000409538.5 |